Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41, 145–151.
Leng, W., Ni, X., Sun, C., Lu, T., Malovannaya, A., Jung, S.Y., Huang, Y., Qiu, Y., Sun, G., Holt, M.V., et al. (2017). Proof-of-concept workflow for establishing reference intervals of human urine proteome for monitoring physiological and pathological changes. EBioMedicine 18, 300–310.
Gao, Y. (2019). Now is the time to test early urinary biomarkers in large-scale human samples. Sci China Life Sci 62, 851–853.
Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., Liu, L., Shan, H., Lei, C.L., Hui, D.S.C., et al. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382, 1708–1720.
Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L., et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273.
This work was supported by the National Key R&D Program of China (2018YFA0507503).
Compliance and ethics The author(s) declare that they have no conflict of interest.
About this article
Cite this article
Ni, X., Sun, C., Tian, Y. et al. Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?. Sci. China Life Sci. (2020). https://doi.org/10.1007/s11427-020-1759-4